Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020)
Praxis Precision Medicines (PRAX) posted quarterly Minority Interest of $111.9 million for Q3 2020, up 993.87% year-over-year from $10.2 million in Q4 2019, and up 933.36% quarter-over-quarter from $10.8 million in Q2 2020.
Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020) Analysis & Trends
Praxis Precision Medicines' Minority Interest history runs 2 years deep, the most recent figure standing at $111.9 million for Q3 2020.
- In Q3 2020, Minority Interest rose 993.87% year-over-year to $111.9 million; the TTM figure through Sep 2020 stood at $111.9 million (up 993.87% YoY), while the FY2019 annual figure was $9.9 million, changed N/A from the prior year.
- Minority Interest for Q3 2020 stood at $111.9 million, up from $10.8 million in the prior quarter.
- The five-year high for Minority Interest was $111.9 million in Q3 2020, with the low at $9.9 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.10 Bn | 131.24 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.66 Bn | 76.67 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.59 Bn | 59.40 Bn | 1.37 Bn |
| 4 | Moderna | 60.02 Bn | 54.88 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.64 Bn | 36.55 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.90 Bn | 28.59 Bn | 992.69 Mn |
| 7 | Royalty Pharma | 27.38 Bn | 26.55 Bn | - |
| 8 | BioNTech SE | 27.36 Bn | 8.97 Bn | 668.28 Mn |
| 9 | Insmed | 26.66 Bn | 25.50 Bn | 358.27 Mn |
| 10 | Praxis Precision Medicines | 10.86 Bn | 10.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 111.89 Mn |
| Jun 30, 2020 | 10.83 Mn |
| Dec 31, 2019 | 9.93 Mn |
| Sep 30, 2019 | 10.23 Mn |